RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,040 Posts.
    lightbulb Created with Sketch. 481
    yes with the iv first in human trials starting tomorrow and the time frame for data flow of results so quick, i think we maybbe right on the cusp of a breakout here
    the burns trial data should be available soon and application to new patients there ongoing- but as we know the results have been spectacular!
    the combination of the burns trial success and the absence of toxicity from the iv trials should really launch this stock
    i cant wait very exciting
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.